Efficacy and tolerability of ketoprofen 200 mg controlled-release cps vs indomethacin 50 mg cps in patients with symptomatic hip osteoarthritis

Minerva Medica

Volumn 88, Issue 10, 1997, Pages 383-391

  Marcolongo, R ^a   Canesi, B ^a   Ferri, S ^a   Oriente, P ^a   Perpignano, G ^a   Serni, U ^a   Tirri, G ^a   Trotta, F ^a   Dal Fra, A ^a   Lucchini, M ^a  

^a Rhone Poulenc Rorer   (Italy)

Author keywords

Ketoprofen; Osteoarthritis, hip

Indexed keywords

INDOMETACIN; KETOPROFEN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; COXITIS; DATA ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HIP OSTEOARTHRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; VERTIGO;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAPSULES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INDOMETHACIN; KETOPROFEN; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; PATIENT SATISFACTION;

EID: 9844256438     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)